Loading clinical trials...
Loading clinical trials...
A 6-Week Randomised, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy of Lurasidone Adjunctive Therapy in Improving Cognitive Functioning in Euthymic Bipolar Disorder Patients (ELICE-BD)
Conditions
Interventions
lurasidone
Placebo
Locations
9
United States
The Brigham and Women's Hospital, Department of Psychiatry
Boston, Massachusetts, United States
University Hospitals Cleveland Medical Center
Cleveland, Ohio, United States
UBC Mood Disorders Center
Vancouver, British Columbia, Canada
Department of Psychiatry, University of Occupational and Environmental Health
Kitakyushu, Fukuoka, Japan
Department of Neuropsychiatry, Kansai Medical University
Moriguchi-shi, Osaka, Japan
Department of Psychiatry, Hokkaido University Graduate School of Medicine
Kita-ku, Sapporo, Japan
Start Date
May 8, 2017
Primary Completion Date
December 31, 2024
Completion Date
December 31, 2024
Last Updated
February 14, 2025
NCT07140913
NCT07172516
NCT06370988
NCT04480918
NCT07404085
NCT06758414
Lead Sponsor
Lakshmi N Yatham
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions